Guidance for the pharmacological management of acne vulgaris.
| Autor: | Valente Duarte de Sousa IC; Department of Dermatolog, Hospital ABC Campus Santa Fe, Mexico City, Mexico. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Expert opinion on pharmacotherapy [Expert Opin Pharmacother] 2022 Jan; Vol. 23 (1), pp. 49-62. Date of Electronic Publication: 2021 Nov 01. |
| DOI: | 10.1080/14656566.2021.1990263 |
| Abstrakt: | Introduction: Many international guidelines and expert consensuses are available to help the clinician diagnose and treat acne vulgaris; however, a simplified practical guidance that integrates current existing published recommendations is still lacking. This article aims to give practical and simplified insight into the treatment of acne. Areas Covered: Herein, the author discusses the treatment of comedonal, papulopustular, and nodular/cystic/conglobate acne. The author also proposes a simplified treatment escalation strategy that is based on disease severity and extension, starting with topical treatments for mild cases and progressing over to systemic therapies in more severe cases. Expert Opinion: The ideal acne treatment would simultaneously and safely target all the pathogenic factors implicated in the appearance of acne lesions with minimal side effects. Since no such treatment currently exists, combination therapies are usually recommended for most types of acne. A major limitation in choosing an appropriate treatment plan is the discrepant use of classification systems across the published literature making it difficult to draw clear and succinct conclusions about the recommendations given. Acne is not a traditional infectious disease and so while antibiotics may improve symptoms, they do not reliably resolve the condition. Thus, there is currently a tendency to opt for antibiotic-sparing treatment strategies whenever possible. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|